ARMATA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 5.18 thousand shares for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2016-11-10
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-09-30 was 1.08K shares, a 99.21% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-06-30 was 100.00 shares.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-03-31 was 4.00K shares.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2015-12-31 was 10.74K shares.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2015 was 147.87K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2016-09-30 | 1.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 1.18K shares derived: sum of 2 quarters · filed 2016-11-10 | 5.18K shares 10-Q · filed 2016-11-10 | 15.93K shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 100.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 4.10K shares 10-Q · filed 2016-08-15 | 14.85K shares derived: sum of 3 quarters · filed 2016-08-15 | 152.03K shares derived: sum of 4 quarters · filed 2016-08-15 |
| 2016-03-31 | 4.00K shares 10-Q · filed 2016-05-12 | 14.74K shares derived: sum of 2 quarters · filed 2016-05-12 | 151.93K shares derived: sum of 3 quarters · filed 2016-05-12 | |
| 2015-12-31 | 10.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 147.93K shares derived: sum of 2 quarters · filed 2016-03-30 | 147.87K shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 137.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | 137.12K shares 10-Q · filed 2015-11-16 | ||
| 2015-06-30 | -60.00 shares 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |